tiprankstipranks
Trending News
More News >
Natural Alternatives International (NAII)
NASDAQ:NAII
Advertisement

Natural Alternatives International (NAII) AI Stock Analysis

Compare
85 Followers

Top Page

NAII

Natural Alternatives International

(NASDAQ:NAII)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 4o)
Rating:45Neutral
Price Target:
$3.00
▲(1.35% Upside)
Natural Alternatives International's stock score is primarily impacted by its financial performance, which highlights significant challenges in profitability and cash flow. Technical analysis suggests a bearish trend, while valuation metrics indicate potential overvaluation. The absence of earnings call data and corporate events leaves these areas unaddressed.

Natural Alternatives International (NAII) vs. SPDR S&P 500 ETF (SPY)

Natural Alternatives International Business Overview & Revenue Model

Company DescriptionNatural Alternatives International (NAII) is a leading provider of contract manufacturing services and nutritional products, specializing in the development and production of innovative dietary supplements and functional foods. The company operates primarily in the health and wellness sector, focusing on high-quality, science-based formulations that cater to the growing demand for natural and organic products. NAII's core offerings include a diverse range of nutritional supplements, private label products, and custom formulations for various clients across the globe, emphasizing quality and compliance with industry standards.
How the Company Makes MoneyNatural Alternatives International generates revenue through several key streams, primarily from its contract manufacturing services, where it partners with brands to produce dietary supplements and functional foods under private labels. The company also earns income from the sale of its proprietary products, which are marketed directly to consumers and distributors. Additionally, NAII benefits from strategic partnerships with health and wellness brands that enable collaborative product development, leveraging its expertise in formulation and manufacturing. The company's focus on quality, compliance, and innovation has positioned it favorably in a competitive market, driving consistent revenue growth.

Natural Alternatives International Financial Statement Overview

Summary
Natural Alternatives International faces financial challenges, with declining profitability and cash flow issues. While revenue has shown some growth, the company struggles with operational inefficiencies and increasing leverage. The negative return on equity and cash flow constraints highlight the need for strategic improvements to enhance financial stability and shareholder value.
Income Statement
45
Neutral
Natural Alternatives International has experienced fluctuating revenue growth, with a recent positive growth rate of 3.27% after a decline in previous years. However, profitability metrics such as the gross profit margin (6.95%) and net profit margin (-10.48%) indicate challenges in maintaining profitability. The negative EBIT and EBITDA margins further highlight operational inefficiencies.
Balance Sheet
50
Neutral
The company's debt-to-equity ratio of 0.86 suggests moderate leverage, but the increasing trend in debt levels is concerning. The return on equity is negative, reflecting recent net losses and indicating inefficiencies in generating returns for shareholders. The equity ratio is not available, limiting a full assessment of financial stability.
Cash Flow
40
Negative
Cash flow analysis reveals a significant decline in free cash flow growth (-169.76%), indicating potential liquidity issues. The operating cash flow to net income ratio is low at 0.21, suggesting challenges in converting income into cash. The free cash flow to net income ratio of 0.39 further underscores cash flow constraints.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue129.72M129.58M113.80M154.01M170.97M178.52M
Gross Profit9.15M9.01M6.87M18.16M30.51M30.44M
EBITDA-5.27M-5.26M-4.46M11.09M20.66M16.58M
Net Income-13.57M-13.57M-7.22M2.52M10.71M10.77M
Balance Sheet
Total Assets166.29M368.00K162.34M134.15M146.00M120.28M
Cash, Cash Equivalents and Short-Term Investments12.32M12.32M11.98M13.60M21.83M32.13M
Total Debt59.03M59.03M60.29M30.93M31.84M16.48M
Total Liabilities97.86M97.86M79.75M45.38M57.48M40.20M
Stockholders Equity68.43M68.43M82.59M88.77M88.52M80.08M
Cash Flow
Free Cash Flow2.32M2.32M-4.51M-6.50M-14.62M15.70M
Operating Cash Flow5.93M5.93M-1.50M7.02M11.87M20.81M
Investing Cash Flow-3.61M-3.61M-3.02M-13.47M-26.46M-5.04M
Financing Cash Flow-1.97M-1.97M2.89M-1.78M4.29M-14.11M

Natural Alternatives International Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2.96
Price Trends
50DMA
2.99
Negative
100DMA
3.28
Negative
200DMA
3.40
Negative
Market Momentum
MACD
-0.01
Negative
RSI
56.24
Neutral
STOCH
65.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NAII, the sentiment is Neutral. The current price of 2.96 is above the 20-day moving average (MA) of 2.75, below the 50-day MA of 2.99, and below the 200-day MA of 3.40, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 56.24 is Neutral, neither overbought nor oversold. The STOCH value of 65.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NAII.

Natural Alternatives International Risk Analysis

Natural Alternatives International disclosed 22 risk factors in its most recent earnings report. Natural Alternatives International reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Natural Alternatives International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$172.42M22.4621.88%3.91%-1.39%
70
Outperform
$313.52M22.089.52%6.62%-7.85%
66
Neutral
$88.84M9.2733.31%2.33%16.77%143.30%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
$375.49M23.093.20%5.88%-68.62%
45
Neutral
$16.86M-1.22-17.98%13.83%-82.27%
43
Neutral
$108.35M-0.20-75.51%-10.13%-532.32%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NAII
Natural Alternatives International
2.96
-1.42
-32.42%
NATR
Nature's Sunshine Products
17.92
0.49
2.81%
HAIN
Hain Celestial
1.20
-6.05
-83.45%
USNA
USANA Health
19.13
-22.16
-53.67%
LFVN
LifeVantage
7.40
-6.47
-46.65%
FTLF
FitLife Brands
18.36
1.46
8.64%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 06, 2025